Metabolism

Metabolic Syndrome: Diagnosis, Risks & Evidence-Based Treatment

Medically reviewed by Medical Advisory Board Last reviewed 2026-05-13

Understanding the cluster of conditions that dramatically raises cardiovascular and diabetes risk

Metabolic syndrome affects roughly 1 in 3 U.S. adults and increases heart disease risk by 2× and type 2 diabetes risk by 5×. Diagnosis requires meeting 3 of 5 specific clinical criteria defined by the AHA/NHLBI.

Metabolic syndrome is not a single disease but a cluster of interconnected metabolic abnormalities — abdominal obesity, insulin resistance, dyslipidemia, and hypertension — that together dramatically amplify cardiovascular and diabetes risk. The National Cholesterol Education Program (NCEP ATP III) criteria, updated by the AHA/NHLBI in 2005, remain the standard diagnostic framework.

Despite its prevalence, metabolic syndrome is frequently undiagnosed because individual components (slightly elevated blood pressure, borderline triglycerides) may not trigger treatment in isolation. The syndrome's danger lies in the synergy between its components — the whole is far more dangerous than the sum of its parts. The common upstream driver is insulin resistance — our metabolic health guide explains how insulin resistance develops and why it precedes every component.

Want expert help with your metabolic health?

We can match you with a metabolic-medicine specialist who understands this area — so you get the right doctor, not just any doctor.

Book An Appointment With A Specialist →

Diagnostic Criteria for Metabolic Syndrome

A diagnosis requires meeting 3 or more of these 5 criteria (AHA/NHLBI harmonized definition, 2009):

CriterionThreshold
Waist circumference≥40 in (102 cm) men; ≥35 in (88 cm) women
Triglycerides≥150 mg/dL (or on medication)
HDL cholesterol<40 mg/dL men; <50 mg/dL women (or on medication)
Blood pressure≥130/85 mmHg (or on medication)
Fasting glucose≥100 mg/dL (or on medication)

Note: The IDF criteria use lower waist circumference cut-offs for non-European ethnicities (e.g., ≥90 cm for Asian men, ≥80 cm for Asian women).

Health Risks of Metabolic Syndrome

Metabolic syndrome confers a 2× increased risk of cardiovascular disease (heart attack, stroke) and a 5× increased risk of type 2 diabetes (Lancet, 2005). Additional associated risks include:

  • Non-alcoholic fatty liver disease (NAFLD) — present in up to 90% of patients with metabolic syndrome
  • Chronic kidney disease — insulin resistance impairs renal function over decades. Our kidney function test guide explains how to interpret eGFR and creatinine if you want to see where you currently stand.
  • Polycystic ovary syndrome (PCOS) — metabolic syndrome is present in 33–47% of women with PCOS
  • Obstructive sleep apnea — bidirectional relationship with metabolic dysfunction
  • Certain cancers — especially colorectal, breast (postmenopausal), and endometrial, linked to hyperinsulinemia
  • Alzheimer's disease — sometimes called "type 3 diabetes" due to insulin resistance in the brain

Treatment: Lifestyle as First-Line Therapy

The AHA emphasizes lifestyle modification as first-line therapy for metabolic syndrome, with pharmacotherapy targeting individual components when needed:

  • Weight loss: 7–10% body weight reduction resolves metabolic syndrome in ~50% of cases (Look AHEAD trial data)
  • Exercise: 150 minutes/week of moderate-intensity aerobic exercise plus 2 sessions of resistance training. Exercise improves insulin sensitivity independent of weight loss.
  • Mediterranean diet: The PREDIMED trial showed a 30% reduction in cardiovascular events with a Mediterranean diet supplemented with extra-virgin olive oil or nuts
  • Pharmacotherapy: Statins for dyslipidemia, ACE inhibitors/ARBs for hypertension (preferred over beta-blockers which worsen insulin resistance), metformin for glucose management in appropriate candidates, and GLP-1 receptor agonists which address multiple components simultaneously

Metabolic Syndrome and Fatty Liver Disease (NAFLD/MASLD)

Fatty liver disease — now more precisely called metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) — is one of the most common and most overlooked complications of metabolic syndrome. As noted above, up to 90% of people with metabolic syndrome have some degree of fatty liver, and the relationship runs in both directions: insulin resistance drives fat accumulation inside liver cells, and a fatty liver in turn produces more inflammatory signaling that worsens insulin resistance elsewhere in the body.

Fatty liver itself is usually silent — it rarely causes symptoms until it progresses to inflammation or fibrosis. This is why it's typically discovered incidentally, either on an abdominal ultrasound ordered for another reason or through mildly elevated liver enzymes on routine bloodwork. If your ALT or AST come back high alongside any of the five metabolic syndrome criteria, fatty liver is the most likely explanation — see our liver function test guide for how to read an ALT/AST pattern and what levels warrant further workup.

The encouraging part: fatty liver linked to metabolic syndrome is highly responsive to the same interventions that address the syndrome itself. Losing 7–10% of body weight, cutting refined carbohydrates and added sugar, and increasing physical activity can meaningfully reduce liver fat within months — often before fasting glucose or blood pressure fully normalize.

How to test metabolic markers at home

You don't need a lab appointment to check your own metabolic markers — a few at-home kits mail you a collection kit and return physician-reviewed results online within days:

A1CNow SelfCheck, A1C Home Test, Includes Analyzer and 4 Tests, Displays Results in 5 Minutes, For Monitoring Glycemic Control in People with Diabetes, Fingerstick Sample
A1CNow SelfCheck, A1C Home Test, Includes Analyzer and 4 Tests, Displays Results in 5 Minutes, For Monitoring Glycemic Control in People with Diabetes, Fingerstick Sample
A1CNOW
View on Amazon →
Everlywell At-Home HbA1c Lab Test for Women and Men, Measures Hemoglobin A1c for Accurate Results from CLIA-Certified Labs Within Days, for Ages 18 Plus
Everlywell At-Home HbA1c Lab Test for Women and Men, Measures Hemoglobin A1c for Accurate Results from CLIA-Certified Labs Within Days, for Ages 18 Plus
Everlywell
View on Amazon →

Prefer to order direct? The Everlywell HbA1c Test uses a CLIA-certified lab, physician-reviewed results, and prepaid return shipping.

What to Look For in a Continuous Glucose Monitor (CGM)

Over-the-counter CGMs like Dexcom Stelo and Abbott Lingo now sell without a prescription. Check the wear time (14–15 days per sensor), whether it reads to your phone or needs a separate device, and the monthly cost. For seeing how your own body responds to meals, a month or two is usually enough — you don't need to wear one forever.

Stelo Glucose Biosensor & App by Dexcom - A Leader in Continuous Glucose Monitoring (CGM). 24/7 Tracking & Personalized Insights to Reveal Patterns. 2-Pack (Up to 15 Days Each). iOS & Android.
Stelo Glucose Biosensor & App by Dexcom - A Leader in Continuous Glucose Monitoring (CGM). 24/7 Tracking & Personalized Insights to Reveal Patterns. 2-Pack (Up to 15 Days Each). iOS & Android.
Stelo
View on Amazon →
Stelo 1 pack
Stelo 1 pack
Stelo
View on Amazon →

What Makes a Good Fiber Supplement

For blood-sugar and cholesterol support you want SOLUBLE fiber — psyllium husk is the best studied. Start with one teaspoon and build up with plenty of water to avoid bloating, and take it 10–15 minutes before carb-heavy meals. Choose an unsweetened, additive-free powder or capsule.

NOW Foods Supplements, Psyllium Husk Caps 500 mg, Non-GMO Project Verified, Natural Soluble Fiber, Intestinal Health*, 200 Veg Capsules
NOW Foods Supplements, Psyllium Husk Caps 500 mg, Non-GMO Project Verified, Natural Soluble Fiber, Intestinal Health*, 200 Veg Capsules
NOW Foods
View on Amazon →
Metamucil, Psyllium Husk GLP-1 Friendly Fiber Capsules, 300 Capsules, 3-in-1 Fiber Supplement, Daily Psyllium Husk Fiber Capsules Help Support Digestive Health by Promoting Regularity*
Metamucil, Psyllium Husk GLP-1 Friendly Fiber Capsules, 300 Capsules, 3-in-1 Fiber Supplement, Daily Psyllium Husk Fiber Capsules Help Support Digestive Health by Promoting Regularity*
Metamucil
View on Amazon →

Frequently Asked Questions

Can metabolic syndrome be reversed?

Yes. Unlike many chronic conditions, metabolic syndrome is highly reversible with lifestyle changes. The Finnish Diabetes Prevention Study showed that participants who achieved modest weight loss (5–7%), increased physical activity, and improved diet quality reversed metabolic syndrome at rates of 40–60% over 3 years. The key is addressing insulin resistance — the common upstream driver.

What is the difference between metabolic syndrome and diabetes?

Metabolic syndrome is a cluster of risk factors (abdominal obesity, high triglycerides, low HDL, high blood pressure, elevated fasting glucose) that precedes and predicts diabetes. Type 2 diabetes is diagnosed when fasting glucose exceeds 126 mg/dL or HbA1c exceeds 6.5%. You can have metabolic syndrome without diabetes, but metabolic syndrome increases diabetes risk by 5-fold.

What doctor treats metabolic syndrome?

Endocrinologists, cardiologists, and internal medicine physicians commonly manage metabolic syndrome. However, because it involves multiple organ systems, a coordinated approach is ideal. Functional and preventive medicine practitioners often provide the most comprehensive management because they address root causes (insulin resistance, inflammation, lifestyle) rather than treating each component separately with different medications.

Does metabolic syndrome look different in women?

The five diagnostic criteria are the same for everyone, but two of them use sex-specific cutoffs (waist circumference ≥35 inches for women vs. ≥40 inches for men, and HDL cholesterol below 50 mg/dL for women vs. below 40 mg/dL for men) because women naturally carry more subcutaneous fat and tend to run higher HDL than men at the same underlying metabolic risk. Presentation also shifts with life stage: premenopausal women are relatively protected by estrogen's favorable effect on fat distribution and insulin sensitivity, but that protection erodes quickly during perimenopause and menopause, when visceral fat, triglycerides, and blood pressure can all move in the wrong direction within just a few years. Metabolic syndrome is also especially common in women with PCOS, often appearing decades before the menopausal transition — see our PCOS guide for how that connection works.

Topic updates

Get the weekly metabolic health roundup

Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.

No spam. Unsubscribe anytime.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.

Check Where You Stand

Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.

Take the Free Assessment →

Free · Takes 5 minutes · Instant results

Continue Reading

← Back to Metabolic Health

Related Topics

2026 Metabolic Guideline Tracker — Current Versions and What Changed

Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. As an Amazon Associate we earn from qualifying purchases. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.